This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Both vehicle types have fee trade-offs. This guide shows how expense ratios and additional costs stack up to help you pick the cheaper option.
28,162 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Wells Fargo agreed to a $110 million discrimination settlement, prompting a cautious but constructive market response...
As the U.S. labor market tightens, veterans are increasingly finding a clear path into high-demand trades. This repor...
Realtracs warns of a June 1 cutoff for the Zillow feed unless updated IDX rules are met. The move could remake listin...
SMCI and Gorilla Technology stock fell sharply after a $2 billion India AI infrastructure deal. Investors are weighin...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
Arm Holdings faces macro headwinds as the Fed signals restraint. Investors are weighing a buy, hold, sell: holdings f...
If you’re thinking about buying spacex, you’re not alone. Before you buy, ask three foundational questions that cover...
ServiceNow stock sits in the mid-$90s as AI disruption reshapes enterprise software. This article lays out a fresh 20...
A Paris court has ordered TotalEnergies to report the climate risks linked to its fuel sales within six months, marki...
Analysts warn that the CLARITY Act's odds of passing have fallen below 50% as the Senate's August recess approaches. ...
As the first half 2026 over wraps up, AI stocks show a rotating leadership. This article highlights two compelling be...